The efficiency of cilostazol for cerebral vasospasm following subarachnoid hemorrhage

Neurological Surgery

Volumn 41, Issue 5, 2013, Pages 393-400

  Murahashi, Takeo ^a   Kamiyama, Kenji ^a   Hara, Keiji ^a   Ozaki, Mitsunori ^a   Mikamoto, Masaaki ^a   Nakagaki, Yusuke ^b   Nakagaki, Yoichi ^b   Nakamura, Hirohiko ^a  

^a Nakamura Memorial Hospital   (Japan)

^b Department of Neurosurgery   (Japan)

Author keywords

Cerebral vasospasm; Cilostazol; Subarachnoid hemorrhage

Indexed keywords

CILOSTAZOL; CYCLIC AMP PHOSPHODIESTERASE; NITRIC OXIDE;

ANEURYSM SURGERY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ARTERY ANEURYSM RUPTURE; BRAIN VASOSPASM; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; ENDOTHELIUM CELL; HUMAN; MAJOR CLINICAL STUDY; SUBARACHNOID HEMORRHAGE; VASCULAR SMOOTH MUSCLE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SUBARACHNOID HEMORRHAGE; TETRAZOLES; TREATMENT OUTCOME; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 84878409687     PISSN: 03012603     EISSN: 18821251     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ameriso SF, Lagos R, Ferreira LM, Fernandez Cisneros L, La Mura AR : Cerebrovascular effects of cilostazol in patients with atherosclerotic disease. J Stroke Cerebrovasc Dis 15 : 273-276, 2006
2. Asano T, Ikegaki I, Suzuki Y, Saito S, Shibuya M : Endothelin and the production of cerebral vasospasm in dogs. Biochem Biophys Res Commun 31 : 1345-1351, 1989
3. Asano T, Matsui T : Current controversies concerning the pathogenetic mechanism underlying cerebral vasospasm. Crit Rev Neurosurg 4 : 369-379, 1994
4. Asano T, Matsui T : The "radical view" of cerebral vasospasm. Crit Rev Neurosurg 6 : 268-280, 1996
5. Barker FG 2nd, Ogilvy CS : Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage : a metaanalysis. J Neurosurg 84 : 405-414, 1996
6. Bavek M, Polin R, Kwan AL, Arthur AS, Kassel NF, LeeKS : Monoclonal antibodies against ICAM-1 and CD 18 attenuate cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke 29 : 1930-1936, 1998
7. Clatterbuck RE, Gailloid P, Ogata L, Gebremariam A, Dietsch GN, Murphy KJ, Tamargo RJ : Prevention of cerebral vasospasm by a humanized ant-CD11/CD18 monoclonal antibody administered after experiment subarachnoid hemorrhage in nonhuman primates. J Neurosurg 99 : 376-382, 2003
8. Elam MB, Heckman J, Crouse JR, Hunninghake DB, Herd JA, Davidson M, Gordon IL, Bortey EB, Forbes WP : Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent clausication. Arteriorscler Thromb Vasc Biol 18 : 1942-1947, 1998
9. Goto S : Cilostazol : potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding. Atheroscler Suppl 6 : 3-11, 2005
10. Hashimoto A, Miyakoda G, Hirose Y, Toyoki M : Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A-and phosphatidylinositol 3-kinase/Akt-dependent mechanism. Atherosclerosis 189 : 350-357, 2006
11. Horowitz A, Menice CB, Laporte R, Morgan KG : Mechanisms of smooth muscle contraction. Physiol Rev 76 : 967-1003, 1996
12. Ide K, Yamakawa K, Nakagomi T, Sasaki T, Saito I, Kurihara H, Yosizumi M, Yazaki Y, Takakura K : The role of endothelium in the pathogenesis of vasospasm following subarachnoid hemorrhage. Neurol Res 11 : 101-104, 1989
13. Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS : Treatment of cerebral vasospasm with intraarterial papaverine. J Neurosurg 77 : 848-852, 1992
14. Masaoka H, Suzuki R, Hirata Y, Emori T, Marumo F, Hirakawa K : Raised plasma endothelin in aneurismal subarachnoid hemorrhage. Lancet 2 : 1402, 1989
15. Mizutani M, Okuda Y, Yamashita K : Effect of cilostazol on the production of platelet-derived growth factor in cultured human vascular endothelial cells. Biochem Mol Med 57 : 156-158, 1996
16. Mocco J, Zacharia BE, Komotar RJ, Connolly ES Jr : A review of current and future medical therapies for cerebral vasospasm following aneurismal subarachnoid hemorrhage. Neurosurg Focus 21 : E9, 2006
17. Nishio Y, Kashiwagi N, Takahara H, Hidaka H, Kikkawa R : Cilostazol, a cAMP phosphodiesterase inhibitor, atteniates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-α in vascular endothelial cells. Horm Metab Res 29 : 491-495, 1997
18. Nishizawa S, Nezu N, Uemura K : Direct evidence for a key role of protein kinase C in the development of vasospasm after subarachnoid hemorrhage. J Neurosurg 76 : 635-639, 1992
19. Nishizawa S, Peterson JW, Shimoyama I, Uemura K : Relation between protein kinase C and calmodulin systems in cerebrovascular contraction : Investigation of the pathogenesis of vasospasm after subarachnoid hemorrhage. Neurosurgery 31 : 711-716, 1992
20. Otsuka K, Suzuki Y, Tanazawa T, Hattori K, Yamamoto N, Takayasu M, Shibuya M, Yoshida J : Interleukin-6 and development of vasospasm after subarachnoid hemorrhage. Act Neurochir (Wein) 140 : 943-951, 1998
21. Otsuki M, Saito H, Xu X, Sumitani S, Kouhara H, Kurabayashi M, Kasayama S : Cilostazol repress vascular cell adhesion molecule-1 gene transcription via inhibiting NF-κB binding to its recognition sequence. Atherosclerosis 158 : 121-128, 2001
22. Park SY, Lee JH, Kim CD, Lee WS, Park WS, Han J, Kwak YG, Kim KY, Hong KW : Cilostazol suppresses superoxide production and expression of adhesion molecules in human endothelial cells via medication of cAMP-dependent protein kinase-mediated maxi-K channel activation. J Pharmacol Exp Ther 317 : 1238-1245, 2006
23. Pradilla G, Wang PP, Legnani FG, Ogata L, Dietsch GN, Tamargo RJ : Prevention of vasospasm by anti-CD11/CD18 monoclonal antibody therapy following subarachnoid hemorrhage in rabbits. J Neurosurg 101 : 88-92, 2004
24. Rasmussen H, Takuwa Y, Park S : Protein kinase C in the regulation of smooth muscle contraction. FASEB J 1 : 177-185, 1987
25. Saito I, Ueda Y, Sano K : Significance of vasospasm in the treatment of ruptured intracranial aneurysms. J Neurosurg 47 : 412-429, 1977
26. Suzuki Y, Osuka K, Noda A, Tanazawa T, Takayasu M, Shibuya M, Yoshida J : Nitric oxide metabolites in the cisternal cerebral spinal fluid of patients with subarachnoid hemorrhage. Neurosurgery 41 : 807-812, 1997
27. Tachibana E, Harada T, Shibuya M, Saito K, Takaya M, Suzuki Y, Yosida J : Intra-arterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid hemorrhage. Acta Neurochir (Wein) 141 : 13-19, 1999
28. Takahashi S, Oida K, Fujiwara R, Maeda H, Hayashi S, Takai H, Tamai T, Nakai T, Miyabo S : Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture. J Cardiovasc Pharmacol 20 : 900-906, 1992
29. Tanaka K, Gotoh F, Fukuuchi Y, Amano T, Uematsu D, Kawamura J, Yamawaki T, Itoh N, Obara K, Muramatsu K : Effects of a selective inhibitor of cyclic AMP phosphodiesterase on the pial microcirculation in feline cerebral ischemia. Stroke 20 : 668-673, 1989
30. Yamaguchi M, Nishizawa S, Mizutani A, Namba H : Multifaceted effects of selective inhibitor of phosphodiesterase III, cilostazol, for cerebral vasospasm after subarachnoid hemorrhage in a dog model. Cerebrovasc Dis 28 : 135-142, 2009